E N D
1. 1 ACHD Guidelines Slide Set
2. 2
3. 3
4. 4
5. 5 Top 10 Points to Remember from ACHD Guidelines 1. The care of ACHD patients should be coordinated by regional ACHD centers of excellence, providing education, patient care and follow-up by specialists for affected individuals.
2. Individual and family psychosocial screening and information should be included in the care of ACHD patients.
3. Thorough clinical evaluation should be undertaken before anticipated non-cardiac surgery, including ECG, chest x-ray, TTE, and blood tests.
4. Counseling before pregnancy is important to ensure that patients understand the risks to both mother and baby, including the risks of transmitting coronary heart disease to their offspring. Any non-cardiac surgery in cyanotic patients, however minor, is potentially life-threatening and should be coordinated with regional centers of excellence.
5. Pacemaker implantation can be beneficial in ACHD patients, but access may be challenging and implantation should be performed at centers where staff is familiar with unusual anatomy of congenital heart defects. ACHD = adults with congenital heart disease; TTE = transthoracic echocardiogramACHD = adults with congenital heart disease; TTE = transthoracic echocardiogram
6. 6 Top 10 Points to Remember on ACHD Guidelines 6. Closure of a secundum atrial septal defect, either percutaneously or surgically, is indicated for right atrial and right ventricular enlargement with or without symptoms.
7. Primary imaging and hemodynamic assessment of aortic stenosis and aortic valve disease are recommended by echocardiography-Doppler to evaluate aortic stenosis or aortic regurgitation, left ventricular size, function and mass, and dimensions and anatomy of the ascending aorta and associated lesions.
8. Lifelong cardiology follow-up is recommended for all patients with aortic valve disease.
9. All patients with tetralogy of Fallot should have regular follow-up with a cardiologist with expertise in ACHD, the frequency of which may be determined by the extent and degree of residual abnormalities.
10. There is a lack of scientific evidence demonstrating proven benefit for IE prophylaxis, although prophylaxis is reasonable in patients with CHD with the highest risk for adverse outcome from infective endocarditis.
7. 7
8. 8
9. 9
10. 10
11. 11 Personnel and Services Recommended for Regional ACHD Centers Data compiled from Table 2, pg. 217, Personnel and Services Recommended for Regional ACHD CentersData compiled from Table 2, pg. 217, Personnel and Services Recommended for Regional ACHD Centers
12. 12 Personnel and Services Recommended for Regional ACHD Centers Data compiled from Table 2, pg. 217, Personnel and Services Recommended for Regional ACHD Centers
Data compiled from Table 2, pg. 217, Personnel and Services Recommended for Regional ACHD Centers
13. 13 Personnel and Services Recommended for Regional ACHD Centers Data compiled from Table 2, pg. 217, Personnel and Services Recommended for Regional ACHD Centers
Data compiled from Table 2, pg. 217, Personnel and Services Recommended for Regional ACHD Centers
14. 14 Personnel and Services Recommended for Regional ACHD Centers Data compiled from Table 2, pg. 217, Personnel and Services Recommended for Regional ACHD Centers
Data compiled from Table 2, pg. 217, Personnel and Services Recommended for Regional ACHD Centers
15. 15 Personnel and Services Recommended for Regional ACHD Centers Data compiled from Table 2, pg. 217, Personnel and Services Recommended for Regional ACHD Centers
Data compiled from Table 2, pg. 217, Personnel and Services Recommended for Regional ACHD Centers
16. 16
17. 17
18. 18
19. 19 Access to Care
20. 20 Access to Care
21. 21 Access to Care
22. 22 Access to Care
23. 23 Access to Care
24. 24 Access to Care
25. 25 Access to Care
26. 26 Access to Care
27. 27 Access to Care
28. 28
29. 29 Psychosocial Issues
30. 30 Psychosocial Issues
31. 31 Psychosocial Issues
32. 32 Psychosocial Issues
33. 33
34. 34 Psychosocial Issues
35. 35
36. 36 Infective Endocarditis
37. 37 Infective Endocarditis
38. 38 Infective Endocarditis
39. 39 Infective Endocarditis
40. 40 Infective Endocarditis
41. 41 Infective Endocarditis
42. 42 Infective Endocarditis
43. 43 Infective Endocarditis
44. 44
45. 45 Noncardiac Surgery
46. 46 Noncardiac Surgery
47. 47 Noncardiac Surgery
48. 48
49. 49 Pregnancy and Contraception
50. 50 Pregnancy and Contraception
51. 51 Pregnancy and Contraception
52. 52
53. 53 Arrhythmia Diagnosis and Management
54. 54 Arrhythmia Diagnosis and Management
55. 55 Arrhythmia Diagnosis and Management
56. 56 Arrhythmia Diagnosis and Management
57. 57
58. 58 Hematologic Problems
59. 59
60. 60 General Health Issues for Cyanotic Patients
61. 61
62. 62 Atrial Septal Defect Closures
63. 63 Atrial Septal Defect Closures
64. 64 Atrial Septal Defect Closures
65. 65 Atrial Septal Defect Closures
66. 66
67. 67 Surgical Ventricular Septal Defect Closure
68. 68 Surgical Ventricular Septal Defect Closure
69. 69 Interventional Catheterization for VSD
70. 70
71. 71 Aortic Valve Repair/Replacement and Aortic Root Replacement
72. 72 Aortic Valve Repair/Replacement and Aortic Root Replacement
73. 73 Aortic Valve Repair/Replacement and Aortic Root Replacement
74. 74 Aortic Valve Repair/Replacement and Aortic Root Replacement
75. 75 Aortic Valve Repair/Replacement and Aortic Root Replacement
76. 76 Aortic Valve Repair/Replacement and Aortic Root Replacement
77. 77 Aortic Valve Repair/Replacement and Aortic Root Replacement
78. 78 Aortic Valve Repair/Replacement and Aortic Root Replacement
79. 79 Surgical Intervention for SubAS
80. 80 Surgical Intervention for SubAS
81. 81 Interventional and Surgical Therapy for Supravalvular LVOT
82. 82 Interventional and Surgical Therapy for Supravalvular LVOT
83. 83 Interventional and Surgical Treatment of Coarctation of the Aorta in Adults
84. 84 Interventional and Surgical Treatment of Coarctation of the Aorta in Adults
85. 85 Intervention in Patients With Valvular Pulmonary Stenosis
86. 86 Intervention in Patients With Valvular Pulmonary Stenosis
87. 87 Intervention in Patients With Valvular Pulmonary Stenosis
88. 88 Intervention in Patients With Valvular Pulmonary Stenosis